Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use

By Hoffman S.L.   Doolan D.L.   Sedegah M.   Aguiar J.C.   Wang R.   Malik A.   Gramzinski R.A.   Weiss W.R.   Hobart P.   Norman J.A.   Margalith M.   Hedstrom R.C.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 842-845

Elsevier

Access to resources Recommend Favorite

Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice

By Moreno C.A.   Rodriguez R.   Oliveira G.A.   Ferreira V.   Nussenzweig R.S.   Moya Castro Z.R.   Calvo-Calle J.M.   Nardin E.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 89-99

Elsevier

Access to resources Recommend Favorite

Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya

By Sherwood J.A.   Copeland R.S.   Taylor K.A.   Abok K.   Oloo A.J.   Were J.B.O.   Strickland G.T.   Gordon D.M.   Ballou W.R.   Bales J.D.   Wirtz R.A.   Wittes J.   Gross M.   J. U.Q.   Cryz S.J.   Oster C.N.   Roberts C.R.   Sadoff J.C.  

Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. : 817-827

Elsevier

Access to resources Recommend Favorite

Assembly and expression of a synthetic gene encoding the antigen Pfs48/45 of the human malaria parasite Plasmodium falciparum in yeast

By Milek R.L.B.   Stunnenberg H.G.   Konings R.N.H.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1402-1411

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children

By Genton B.   Al-Yaman F.   Betuela I.   Anders R.F.   Saul A.   Baea K.   Mellombo M.   Taraika J.   Brown G.V.   Pye D.   Irving D.O.   Felger I.   Beck H.-P.   Smith T.A.   Alpers M.P.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 30-41

Elsevier

Access to resources Recommend Favorite